The blood glucose level of neonates delivered by GDM patients is lower than that of non-GDM patients, with increased methylation of maternal PDX1 gene and decreased expression levels of maternal PDX1, NGN3 and Pax6 genes, which is related to changes in neonatal blood glucose levels. This evidence concerns the gene NEUROG3 and gestational diabetes.